Bay City Capital Management IV LLC's Net Worth
$0
Estimate Recalculated Nov 11, 2024 02:49AM EST
Who is Bay City Capital Management IV LLC?
Bay City Capital Management IV LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EnteroMedics Inc, SYNTA PHARMACEUTICALS CORP, NEVRO CORP, NEORX CORP, and CORAUTUS GENETICS INC.
SEC CIK
Bay City Capital Management IV LLC's CIK is 0001359070
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EnteroMedics Inc No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.67% | 840K |
$1.65 | $1,386,000.00 | 4.9M |
Sep 23
| |||
Form 4
| +104.70% | 3.33M |
$1.74 | $2,958,000.00 | 6.5M |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +59.31% | 1.65M |
$1.15 | $1,896,907.75 | 4.43M |
Feb 19
| |||
Form 4
| +1.82% | 49.6K |
$1.10 | $54,560.00 | 2.78M |
Oct 24
| |||
Form 4
| +0.92% | 25K |
$4.50 | $112,500.00 | 2.73M |
Apr 29
| |||
Form 4
| +1.88% | 50K |
$4.50 | $225,000.00 | 2.71M |
Apr 24
| |||
Form 4
| +0.80% | 21K |
$8.66 | $181,860.00 | 2.66M |
Feb 29
| |||
Form 4
| +602.80% | 2.26M |
—
|
—
| 2.64M |
Nov 20
| |||
Form 4
|
∞
| 375K |
$8.00 | $3,000,000.00 | 375K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $243.89
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.28% | -824.17K |
—
|
—
| 1.51M |
Dec 3
| |||
Form 4
| -1.85% | -43.54K |
—
|
—
| 2.31M |
Dec 1
| |||
Form 4
| -39.63% | -1.55M |
—
|
—
| 2.35M |
Sep 4
| |||
Form 4
| -41.17% | -30.00K |
$109.74 | -$3,292,195.83 | 42.88K |
Aug 17 - Aug 19
| |||
Form 4
| -9.60% | -412.24K |
—
|
—
| 3.88M |
May 27
| |||
Form 4
| -22.31% | -1.20M |
$105.47 | -$126,564,000.00 | 4.18M |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEVRO CORP (NVRO) Snapshot price: $5.09
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.18% | -491.83K |
$47.94 | -$23,578,569.90 | 1.73M |
Jun 8
| |||
Form 4
| +9,154.97% | 2.19M |
—
|
—
| 2.22M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEORX CORP No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.44% | 74.97K |
$5.80 | $442,223.16 | 16.93M |
Aug 30
| |||
Form 4
| +0.09% | 4.94K |
$5.75 | $28,381.15 | 5.57M |
Aug 29
| |||
Form 4
| +0.05% | 5.17K |
$5.49 | $28,338.72 | 11.12M |
Aug 14 - Aug 16
| |||
Form 4
| +0.25% | 13.63K |
$5.50 | $74,976.00 | 5.56M |
Aug 10
| |||
Form 4
| +23.18% | 1.04M |
$6.33 | $6,605,456.28 | 5.55M |
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CORAUTUS GENETICS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +48.44% | 4.07M |
$2.43 | $9,880,336.26 | 12.46M |
Aug 8
| |||
Form 4
|
∞
| 8.39M |
—
|
—
| 8.39M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||